CoreFirst Bank & Trust’s CVS Health CVS Stock Holding History

CoreFirst Bank & Trust’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.9K	Hold	202	–	–	0.01%	236
2026 Q1	$14.5K	Hold	202	–	–	0.01%	255
2025 Q4	$16K	Sell	202 -100	-33%	-$7.88K	0.01%	258
2025 Q3	$22.8K	Hold	302	–	–	0.01%	246
2025 Q2	$20.8K	Buy	+302	New	+$19.8K	0.01%	257
2025 Q1	–	Sell	-460	Closed	-$20.6K	–	163
2024 Q4	$20.6K	Hold	460	–	–	0.01%	262
2024 Q3	$28.9K	Buy	+460	New	+$26.8K	0.02%	244
2024 Q2	–	Sell	-1,804	Closed	-$144K	–	172
2024 Q1	$144K	Sell	1,804 -170	-9%	-$13K	0.09%	142
2023 Q4	$156K	Sell	1,974 -1,633	-45%	-$116K	0.1%	134
2023 Q3	$252K	Sell	3,607 -2	-0.1%	-$142	0.18%	108
2023 Q2	$249K	Sell	3,609 -1,936	-35%	-$138K	0.18%	111
2023 Q1	$412K	Sell	5,545 -920	-14%	-$77.1K	0.3%	84
2022 Q4	$602K	Buy	6,465 +520	+9%	+$50.2K	0.46%	51
2022 Q3	$567K	Hold	5,945	–	–	0.49%	47
2022 Q2	$551K	Buy	5,945 +100	+2%	+$9.76K	0.44%	52
2022 Q1	$592K	Hold	5,845	–	–	0.4%	60
2021 Q4	$603K	Hold	5,845	–	–	0.39%	64
2021 Q3	$496K	Hold	5,845	–	–	0.34%	67
2021 Q2	$488K	Hold	5,845	–	–	0.33%	73
2021 Q1	$440K	Hold	5,845	–	–	0.3%	78
2020 Q4	$399K	Buy	+5,845	New	+$380K	0.3%	73

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

CoreFirst Bank & Trust's CVS Position: Q2 2026 in Review

CoreFirst Bank & Trust held its CVS Health (CVS) position steady in Q2 2026 at 202 shares worth $20.9K. The position accounts for 0.01% of the portfolio, ranked #236.

CoreFirst Bank & Trust first reported a position in CVS in Q4 2020 and has held it in 21 quarters since. The position peaked at $603K in Q4 2021. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

CoreFirst Bank & Trust held 202 shares of CVS Health worth $20.9K as of Q2 2026.
CoreFirst Bank & Trust left its CVS Health share count unchanged in Q2 2026.
CVS Health made up 0.01% of CoreFirst Bank & Trust's portfolio in Q2 2026, its #236 holding.
CoreFirst Bank & Trust first reported a position in CVS Health in Q4 2020 and has held it in 21 quarters since.
CoreFirst Bank & Trust's CVS Health position peaked at $603K in Q4 2021.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on CoreFirst Bank & Trust's 13F filing for Q2 2026, filed 5 Aug 2026.